ubmslatePT-logo-ubm

PT Mobile Logo

Topics:

Ovarian Cancer

Ovarian Cancer

Could the approval of bevacizumab for advanced cervical cancer and platinum-resistant ovarian cancer last year lead to patient-specific therapies?

The FDA has approved olaparib, to be marketed under the name Lynparza, for the treatment of advanced ovarian cancer related to defective BRCA genes.

A new app, called ADNEX, helps distinguish between benign and malignant ovarian tumors, potentially improving triage and management decisions.

New research looking at complication rates and cost for oophorectomy and cystectomy favors conventional laparoscopy over robotic surgery.

Maintenance therapy with pazopanib improved progression-free survival by 5.6 months in advanced ovarian cancer patients, according to results of a new study.

The Society of Gynecologic Oncology (SGO) recently issued two new clinical practice statements recommending genetic testing for all women with endometrial and ovarian cancers, regardless of family history.

Being overweight increases a woman’s risk of ovarian cancer, according to a new comprehensive report. The finding offers a way to reduce the risk.

Pages

Subscribe to Ovarian Cancer on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.